It’s becoming more common to treat ulcerative colitis with two biologic medications, or a biologic and a small molecule drug.

It’s becoming more common to treat Crohn’s disease with 2 biologic medications, or a biologic and a small molecule drug. Find out how it works, and who might try it.

Here are six factors to consider and discuss with your doctor before transitioning to a biologic for moderate to severe Crohn's disease.

More than two in three Americans approve of President Biden’s signature legislation, the Inflation Reduction Act. The law is growing our economy, bolstering domestic manufacturing, and spurring ...

Most patients with cutaneous Crohn’s disease present with genital lesions and show good response with biologic therapy, ...

Biologic drugs, made from living organisms and usually taken by injection or infusion, are expensive treatments for complex chronic conditions such as cancer and autoimmune diseases. Biosimilars, ...

EMERYVILLE, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic ...

By Leon Aris in Berlin A small UK-registered biotech company believes it has found an Alzheimer's treatment that is safer, ...

The sterile injectables CDMO market is poised for growth due to the rising demand for biologics, biosimilars, and advanced injectable formats. Opportunities include expansion in large molecule and ...